Item 7.01 Regulation FD Disclosure.

On January 13, 2020, STAAR Surgical Company (the "Company") published a press release reporting selected preliminary financial results for the quarter and fiscal year ended January 3, 2020, a copy of which is furnished as Exhibit 99.1 to this Report and is incorporated herein by this reference. The financial information is unaudited and subject to adjustment in the final audited financial statements to be filed with the Company's Annual Report on Form 10-K. The Company expects to report its complete 2019 financial results on its fourth-quarter and full-year earnings call, which it will hold later in the first quarter of 2020.

On January 13, 2020, the Company issued a press release announcing CE Mark approval from its European Notified Body, DEKRA, expanding the indications of use for the EVO/EVO+ and Visian implantable Collamer lenses (ICL) for myopia and hyperopia, and EVO/EVO+ and Visian toric implantable Collamer lenses for myopia and hyperopia with astigmatism as a supplemental lens in post-cataract IOL (intraocular lens) surgery patients. A copy of the press release is furnished as Exhibit 99.2 to this Report and is incorporated herein by this reference.

Representatives of the Company will give presentations to investors commencing on January 13, 2020. A copy of the slide presentation they will use in their presentations is furnished as Exhibit 99.3 to this Report and is incorporated herein by this reference.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibits 99.1, 99.2 and 99.3 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits





Exhibit No.   Description
99.1            Press release of the Company dated January 13, 2020  .
99.2            Press release of the Company dated January 13, 2020  .
99.3            Slide presentation dated January 13, 2020  .

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses